Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Comment by okgonowon Nov 13, 2024 8:46am
112 Views
Post# 36309905

RE:RE:RE:Seems frothy

RE:RE:RE:Seems frothy
QContinuum1 wrote: If a 400M Euro medical market in Germany isn't enough for Medipharm or it's numerous partners in Germany (one being a massive one), then I don't know how much would be enough.

There is no excuse for Medipharm to not be achieving $10M CDN alone from Germany.  None.




now i am beginning to  think all the price action and volume as of late has everything to do with Germany

Not sure about all the others selling into the german market but with Strada being our partner with their presence and being a known entity to the helth care professionals over there i would think they would be the leaders in tearms of sales.

if I were a doctor and inclined to write prescriptions for canabis med's who would i choose to go with ... a known entity like Strada and their record especially when it comes to drugs, safety and a well known name or some out of country player that they may have never heard of that includes Tillray.

if a patient is eligable i would perscribe a Strada backed Product before anyone elses .

I DK but sure makes sense to me 

the change in the law that was posted shows what types of Doctors can perscribe the Canabis products to their patients and that it only requires the regular prescription type to have the cost covered by the govenment
<< Previous
Bullboard Posts